ask="6.50"
ask_size="1000"
average_daily_volume="1500860"
bid="4.00"
bid_size="200"
book_value="0.21"
change="-0.20"
change_from_200_day_moving_average="-0.25"
change_from_50_day_moving_average="-0.70"
change_from_52_week_high="-2.57"
change_From_52_week_low="2.12"
change_in_percent="-3.68%"
close="5.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71243000"
high="5.51"
high_52_weeks="7.80"
last_trade_date="1/23/2017"
last_trade_price="5.23"
last_trade_size="61248"
last_trade_time="4:00pm"
low="5.21"
low_52_weeks="3.11"
market_capitalization="554.17M"
moving_average_200_day="5.48"
moving_average_50_day="5.93"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="5.43"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="-4.51%"
percent_change_from_50_day_moving_average="-11.83%"
percent_change_from_52_week_high="-32.95%"
percent_change_from_52_week_low="+68.17%"
previous_close="5.43"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="26.11"
price_per_sales="20.38"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="16.17"
stock_exchange="NCM"
symbol="KERX"
volume="1591836"
weeks_range_52="3.11 - 7.80"
